Kuna Iya Buƙatar Sashi na Uku na Allurar COVID-19

Wadatacce

• Bita don

An yi wasu hasashe cewa mRNA COVID-19 alluran rigakafin (karanta: Pfizer-BioNTech da Moderna) na iya buƙatar fiye da allurai biyu don ba da kariya kan lokaci. Kuma yanzu, Shugaba na Pfizer yana tabbatar da cewa tabbas yana yiwuwa.

A cikin wata sabuwar hira da CNBC, Shugaban Kamfanin Pfizer Albert Bourla ya ce "watakila" mutanen da aka yi wa cikakkiyar allurar rigakafin Pfizer-BioNTech COVID-19 za su buƙaci wani kashi a cikin watanni 12.

"Yana da matukar mahimmanci a murkushe tafkin mutanen da za su iya kamuwa da kwayar cutar," in ji shi a cikin hirar. Bourla ya yi nuni da cewa har yanzu masana kimiyya ba su san tsawon lokacin da maganin zai kare daga COVID-19 da zarar an yi wa wani cikakken allurar rigakafin saboda bai isa ba lokacin da aka fara gwajin asibiti a cikin 2020.

A cikin gwaje-gwajen asibiti, maganin Pfizer-BioNTech ya kasance sama da kashi 95 cikin 100 masu tasiri wajen kariya daga cututtukan COVID-19 masu alama. Amma Pfizer ya raba a cikin sanarwar manema labarai a farkon wannan watan cewa rigakafinta ya fi kashi 91 cikin dari bayan watanni shida bisa bayanan gwaji na asibiti. (Mai alaƙa: Yaya Tallafin COVID-19 yake da inganci?)

Gwajin na ci gaba da gudana, kuma Pfizer zai buƙaci ƙarin lokaci da bayanai don gano ko kariya za ta daɗe fiye da watanni shida.

Bourla ya fara canzawa a kan Twitter jim kadan bayan ganawar ta gudana, tare da mutane suna da ra'ayoyi daban-daban. "Mutane sun ruɗe kuma suna jin haushi game da Shugaban Kamfanin Pfizer yana cewa da alama za mu buƙaci harbi na uku a cikin watanni 12 ... Shin ba su taɓa jin labarin rigakafin mura na * shekara-shekara ba? ", wani ya rubuta. "Da alama Shugaban Kamfanin Pfizer yana ƙoƙarin samun ƙarin kuɗi ta hanyar ambaton buƙatar harbi na uku," in ji wani.

Shugaban Kamfanin Johnson & Johnson Alex Gorsky ya kuma fada a CNBC a watan Fabrairu cewa mutane na iya bukatar samun harbin kamfaninsa duk shekara, kamar harbin mura. (An bayar, ba shakka, allurar kamfanin ba ta da '' dakatarwa '' daga hukumomin gwamnati saboda damuwa game da ƙin jini.)

Gorsky ya ce "Abin takaici, yayin da [COVID-19] ke yaduwa, shi ma yana iya canzawa." "Duk lokacin da ya canza, ya zama kamar wani danna bugun kira don yin magana inda za mu iya ganin wani bambance-bambancen, wani maye gurbi wanda zai iya yin tasiri ga ikonsa na kare kwayoyin cutar ko kuma samun wani nau'i na daban ba kawai ga warkewa amma kuma ga maganin alurar riga kafi." (Mai alaƙa: Menene Ainihin Sakamakon Gwajin rigakafin Coronavirus na Gaskiya?)

Amma masana ba su gigice da yuwuwar buƙatar ƙarin allurar rigakafi ba. "Yana da mahimmanci a shirya don kara kuzari da yin nazari," in ji masanin cututtukan cututtuka Amesh A. Adalja, MD, babban malami a Cibiyar Tsaron Lafiya ta Johns Hopkins. "Mun san cewa rigakafi yana raguwa tare da sauran coronaviruse kusan shekara guda, don haka ba zai zama abin mamaki a gare ni ba."

Idan ana buƙatar allurar rigakafi ta uku, a zahiri, "za a iya ƙera shi don yin tasiri kan nau'ikan bambance -bambancen ko aƙalla wasu daga cikinsu," in ji Richard Watkins, MD, ƙwararre kan cutar da farfesa na likitan ciki a Northeast Ohio Medical University. Kuma, idan ana buƙatar allurai na uku don allurar Pfizer-BioNTech, da alama hakan zai kasance gaskiya ga allurar Moderna, ganin cewa suna amfani da irin wannan fasahar mRNA, in ji shi.

Duk da kalaman Bourla (da kuma ƙaramin ciwon hauka da suka ƙirƙira), da gaske ba da daɗewa ba za a san tabbas idan kashi na uku na allurar zai zama gaskiya, in ji Dokta Adalja. "Ba na jin akwai isassun bayanai da za su ja abin," in ji shi. "Ina so in ga bayanai game da sake kamuwa da cuta a cikin mutanen da aka yi wa cikakken rigakafin shekara guda - kuma ba a samar da wannan bayanan ba tukuna."

A yanzu, saƙon yana da sauƙi: Yi allurar rigakafi lokacin da za ku iya, da kuma kula da duk waɗancan ɗabi'un lafiya waɗanda aka nanata tun farkon COVID-19, gami da wanke hannuwanku (daidai), zama gida idan kun ji rashin lafiya, da sauransu. Za mu buƙaci ɗaukar wannan - kamar komai yayin bala'in - mataki ɗaya a lokaci guda.

Bayanai a cikin wannan labarin daidai ne har zuwa lokacin da ake bugawa. Yayin da sabuntawa game da coronavirus COVID-19 ke ci gaba da haɓaka, yana yiwuwa wasu bayanai da shawarwari a cikin wannan labarin sun canza tun farkon bugawa. Muna ƙarfafa ku da ku bincika akai-akai tare da albarkatu kamar CDC, WHO, da sashin kula da lafiyar jama'a na gida don ƙarin sabbin bayanai da shawarwari.

Bita don